SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Group Plc Regulatory News (COA)

Share Price Information for Coats Group Plc (COA)

Share Price is delayed by 15 minutes
Get Live Data
79.95    1.45 (1.85%)
Bid:
79.45
Ask:
79.60
Spread: 0.15 (0.189%)
Market Cap: £1.53b
COA Live PriceLast checked at - London Stock Exchange

Intraday Coats Group Plc Share Chart

Director/PDMR Shareholding

17 Mar 2025 14:00

RNS Number : 9823A
Coats Group PLC
17 March 2025
 

17 March 2025

Coats Group plc

Director/PDMR Shareholding

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

David Paja

 

2

Reason for the notification

a)

Position/status

Chief Executive Officer and Executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, UK emission allowance market participant, auction platform or auctioneer

a)

Name

Coats Group plc

b)

LEI

2138003SPYWGAITNFY17

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Share award constituting a right to acquire Ordinary shares of £0.05

 

GB00B4YZN328

 

b)

Nature of the transaction

1.

Award of nil cost share options under the terms of the Coats Group plc Deferred Annual Bonus Plan ("DABP") as set out below:

 

The DABP awards represent a proportion of the annual bonus awarded for the year ended 31 December 2024 and vest after 3 years from the date of the award. DABP awards are not subject to performance conditions, as the bonus targets in respect of 2024 have already been met, but awards are subject to certain forfeiture and clawback provisions in certain situations such as personal misconduct or a misstatement of results.

2.

Award of nil cost share options under the terms of the Coats Group plc Long Term Incentive Plan ("LTIP") the performance conditions are set out in the attached Appendix 1.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1) DABP

2) LTIP

 Nil

 Nil

220,210

1,541,472

d)

Aggregated information

· - Aggregated volume

· - Price

 

1,761,682

n/a

e)

Date of the transaction

2025-03-14

 

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jacqueline Callaway

 

2

Reason for the notification

a)

Position/status

Chief Financial Officer and Executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, UK emission allowance market participant, auction platform or auctioneer

a)

Name

Coats Group plc

b)

LEI

2138003SPYWGAITNFY17

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Share award constituting a right to acquire Ordinary shares of £0.05

 

GB00B4YZN328

 

b)

Nature of the transaction

1.

Award of nil cost share options under the terms of the Coats Group plc Deferred Annual Bonus Plan ("DABP") as set out below:

 

The DABP awards represent a proportion of the annual bonus awarded for the year ended 31 December 2024 and vest after 3 years from the date of the award. DABP awards are not subject to performance conditions, as the bonus targets in respect of 2024 have already been met, but awards are subject to certain forfeiture and clawback provisions in certain situations such as personal misconduct or a misstatement of results.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1) DABP

 Nil

290,375

d)

Aggregated information

· - Aggregated volume

· - Price

 

290,375

n/a

e)

Date of the transaction

2025-03-14

 

f)

Place of the transaction

Outside a trading venue

 

Enquiry details

 

Investors

Anjali Kotak

Coats Group plc

+44 (0)7880 471350

Media

Richard Mountain / Nick Hasell

FTI Consulting

+44 (0)20 3727 1374

 

Appendix 1

Coats Group plc - 2025 Long Term Incentive Award - Performance Schedule

Introduction

The following schedule sets out the performance conditions that will apply to the 2025 Coats Group PLC Long Term Incentive award. The performance period is 1 January 2025 to 31 December 2027.

 

Performance Measures & Weighting

The award has four performance measures and is weighted as set out below.

Measure

Weighting

(% of total award)

Definition1

 

Coats Group plc Earnings Per Share Compound Annual Growth (CAGR)

30%

The Compound Annual Growth (CAGR) in EPS achieved in the performance period. The Board will consider the CAGR in Normalised EPS which is EPS, adjusted to exclude exceptional items such as property gains or losses and the impact of IAS19 charges (pensions finance) . 

Average Cash Conversion over 3-years (Cash)

20%

The average of the adjusted Free Cash Flow divided by normalised Attributable Profit for each of the three years in the performance period. The adjusted Free Cash Flow is after maintaining the company's asset base ie operating cash flow minus capital expenditures, adjusted for exceptional items such as property gains or losses. 

Total Shareholder Return

25%

The total returns to shareholders which includes share price growth and ordinary dividend payments. The performance condition is measured against a comparator group consisting of the FTSE250 minus investment trusts.

Sustainability

25%

Achievement of 3 independent equally weighted Sustainability goals. 

TOTAL

100%

1. Subject to such adjustments as required by the Committee to ensure the performance condition fulfils its original intent. 

Performance Targets and Vesting Schedule

EPS CAGR (adjusted if necessary)

Threshold

Maximum

EPS CAGR in the period from 2025-2027. Measured from the 2024 base year

 

4%

12%

Vesting (The proportion of the award for this measure that vests)

25%

100%

 

Average Cash Conversion

Threshold

Maximum

Average Cash Conversion over the period 2025 to 2027

 

70%

90%

Vesting (The proportion of the award for this measure that vests)

25%

100%

 

Total Shareholder Return

Threshold

Maximum

Ranking Position vs FTSE250 (excluding investment trusts)

Median

Upper Quartile

Vesting (The proportion of the award for this measure that vests)

25%

100%

 

Sustainability

Threshold

Maximum

Absolute reduction in Scope 1&2 emissions in tonnes from 2019 baseline

 

55%

65%

Absolute reduction in Scope 3 emissions in tonnes from 2019 baseline

 

22%

26%

Percentage of females in senior leadership roles

 

33%

37%

Vesting (The proportion of the award for this measure that vests)

25%

100%

 

There is a proportionate straight-line vesting for performance between each of the targets shown above. 

The range of performance targets have been set with reference to internal planning and external market expectations for the Company's future performance and are considered similarly challenging to the targets set in prior years allowing for current market conditions. The Committee would consider appropriate adjustments to the financial performance targets to extent the Company undertook material acquisitions or divestments, or share buybacks, during the period from 1 January 2025 to 31 December 2027.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUBVORVKUOAAR
Date   Source Headline
8th Jun 20269:23 amRNSHolding(s) in Company
20th May 20264:16 pmRNSResult of AGM
20th May 20267:00 amRNSTrading Statement
14th May 202611:00 amRNSAppointment of Chair
6th May 202611:00 amRNSDirectorate change
24th Apr 20261:15 pmRNSHolding(s) in Company
8th Apr 202611:00 amRNSDirector Declaration
30th Mar 202611:15 amRNSDirector/PDMR Shareholding
24th Mar 202611:08 amRNSHolding(s) in Company
17th Mar 20262:07 pmRNSDirector/PDMR Shareholding
12th Mar 202610:03 amRNSAnnual Financial Report
12th Mar 202610:03 amRNSAnnual Financial Report
5th Mar 20267:00 amRNS2025 Full Year Results
11th Feb 202611:00 amRNSChanges to Director's Responsibilities
9th Feb 20262:07 pmRNSHolding(s) in Company
6th Feb 20262:00 pmRNSDirector Declaration
17th Dec 20252:00 pmRNSDirector/PDMR Shareholding
7th Nov 20257:00 amRNSTrading Statement
5th Nov 20252:45 pmRNSDirector Declaration
30th Oct 20257:00 amRNSCompletion of OrthoLite acquisition
20th Oct 202512:41 pmRNSDirector/PDMR Shareholding
17th Oct 20251:42 pmRNSHolding(s) in Company
6th Oct 20251:06 pmRNSBlock listing Interim Review
16th Sep 20252:00 pmRNSDirector Declaration
12th Sep 20253:22 pmRNSHolding(s) in Company
11th Sep 20253:13 pmRNSHolding(s) in Company
10th Sep 20251:09 pmRNSDirector/PDMR Shareholding
3rd Sep 202512:58 pmRNSHolding(s) in Company
11th Aug 202511:03 amRNSHolding(s) in Company
5th Aug 202510:44 amRNSHolding(s) in Company
31st Jul 202512:39 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSFurther Information re Acquisition of OrthoLite
23rd Jul 20259:26 amRNSHolding(s) in Company
22nd Jul 202510:31 amRNSHolding(s) in Company
21st Jul 20253:25 pmRNSDirector/PDMR Shareholding
21st Jul 20252:30 pmRNSHolding(s) in Company
21st Jul 20252:27 pmRNSHolding(s) in Company
17th Jul 20256:00 pmRNSCoats Group
17th Jul 20257:00 amRNSResults of Capital Raise
16th Jul 20255:47 pmRNSAcquisition - Retail Offer Launch (Replacement)
16th Jul 20254:50 pmRNSAcquisition - Retail Offer Launch
16th Jul 20254:46 pmRNSAcquisition - Capital Raise Launch
16th Jul 20254:45 pmRNSHalf-year Report
16th Jul 20254:45 pmRNSAcquisition
27th Jun 20251:06 pmRNSHolding(s) in Company
24th Jun 20257:00 amRNSDirectorate Change
4th Jun 20251:42 pmRNSDirector/PDMR Shareholding
23rd May 202511:32 amRNSDirector/PDMR Shareholding
21st May 20253:58 pmRNSResult of AGM
21st May 20257:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.